FPFrancesco Pennacchio

Francesco Pennacchio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Francesco Pennacchio has a total of 88 co-authors. Here are the top co-authors by number of shared publications:

  • Elsa Lorthe

    Geneva University Hospitals

    7 shared publications
  • Silvia Stringhini

    Affiliations Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland, School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, Canada, Faculty of Medicine, University of Geneva, Geneva, Switzerland, Edwin S.H. Leong Centre for Healthy Aging, Faculty of Medicine, University of British Columbia, Vancouver, Canada

    7 shared publications
  • Idris Guessous

    Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland

    6 shared publications
  • María-Eugenia Zaballa

    Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland

    6 shared publications
  • Andrew S. Azman

    Johns Hopkins University

    4 shared publications
  • Arnaud G. L’huillier

    Division of General Pediatrics, Department of Woman, Child, and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland

    4 shared publications

Latest Publications

  • Open Access

    Evolving infectious disease dynamics shape school-based intervention effectiveness

    by Javier Perez-Saez, Mathilde Bellon, Justin Lessler, Julie Berthelot, Emma B. Hodcroft, Grégoire Michielin, Francesco Pennacchio, Julien Lamour, Florian Laubscher, Arnaud G. L’hUillier, et al.

    School-based interventions during epidemics are often controversial, as experienced during the COVID-19 pandemic, where reducing transmission had to be weighed against the adverse effects on young children. However, it remains unclear how the broader epidemiologic context influences the effectiveness of these interventions and when they should be implemented. Through integrated modeling of epidemiological and genetic data from a longitudinal school-based surveillance study of SARS-CoV-2 in 2021–2022 (N children = 336, N adults = 51) and scenario simulations, we show how transmission dynamics in schools changed markedly due to strong increases in community-acquired infections in successive periods of viral variants, ultimately undermining the potential impact of school-based interventions in reducing infection rates in the school-aged population. With pandemic preparedness in mind, this study advocates for a dynamic perspective on the role and importance of schools in infectious disease control, one that adapts to the evolving epidemiological landscape shaped by pathogen characteristics and evolution, shifting public health policies, and changes in human behavior.


  • Open Access

    Impact of the COVID-19 pandemic on children and adolescents: determinants and association with quality of life and mental health—a cross-sectional study

    by Viviane Richard, Roxane Dumont, Elsa Lorthe, Andrea Loizeau, Hélène Baysson, María-Eugenia Zaballa, Francesco Pennacchio, Rémy P. Barbe, Klara M. Posfay-Barbe, Idris Guessous, et al.

    Background: The medium-term impact of the COVID-19 pandemic on the wellbeing of children and adolescents remains unclear. More than 2 years into the pandemic, we aimed to quantify the frequency and determinants of having been severely impacted by the COVID-19 pandemic and estimate its impact on health-related quality of life (HRQoL) and mental health. Methods: Data was drawn from a population-based cohort of children and adolescents, recruited between December 2021 and June 2022, in Geneva, Switzerland. The Coronavirus impact scale was used to assess the multidimensional impact of the pandemic on children through parent’s report. A score higher than one standard deviation above the mean was deemed a severe impact. Parents additionally reported about their offspring HRQoL and mental health with validated scales. Determinants of having been severely impacted were assessed with logistic models, as were the associations between having experienced a severe impact and poor HRQoL or mental health. Results: Out of 2101 participants aged 2–17, 12.7% had experienced a severe pandemic impact. Having a lasting health condition, a pandemic-related worsening of lifestyle habits or an unfavorable family environment were associated with having been severely impacted by the pandemic, while a previous anti-SARS-CoV-2 infection was not. Participants who had experienced a severe pandemic impact were more likely to present poor HRQoL (aOR = 3.1; 95% CI 2.3–4.4) and poor mental health (aOR = 3.9; 95% CI 2.5–6.2). Conclusion: The COVID-19 pandemic may have persistent consequences on the wellbeing of children and adolescents, especially among those with health and family vulnerabilities.


  • Open Access

    Prevalence and predictors of psychological distress before, during, and after a COVID-19 pandemic wave in Switzerland, 2021

    by Stephanie Schrempft, Nick Pullen, Hélène Baysson, Ania Wisniak, María-Eugenia Zaballa, Francesco Pennacchio, Peter Vollenweider, Pedro Marques-Vidal, Martin Preisig, Idris Guessous, et al.


  • Open Access

    A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents

    by Roxane Dumont, Viviane Richard, Elsa Lorthe, Andrea Loizeau, Francesco Pennacchio, María-Eugenia Zaballa, Hélène Baysson, Mayssam Nehme, Anne Perrin, Arnaud G. L’huillier, et al.

    Post-COVID syndrome remains poorly studied in children and adolescents. Here, we aimed to investigate the prevalence and risk factors of pediatric post-COVID in a population-based sample, stratifying by serological status. Children from the SEROCoV-KIDS cohort study (State of Geneva, Switzerland), aged 6 months to 17 years, were tested for anti-SARS-CoV-2 N antibodies (December 2021-February 2022) and parents filled in a questionnaire on persistent symptoms in their children (lasting over 12 weeks) compatible with post-COVID. Of 1034 children tested, 570 (55.1%) were seropositive. The sex- and age-adjusted prevalence of persistent symptoms among seropositive children was 9.1% (95%CI: 6.7;11.8) and 5.0% (95%CI: 3.0;7.1) among seronegatives, with an adjusted prevalence difference (ΔaPrev) of 4.1% (95%CI: 1.1;7.3). Stratifying per age group, only adolescents displayed a substantial risk of having post-COVID symptoms (ΔaPrev = 8.3%, 95%CI: 3.5;13.5). Identified risk factors for post-COVID syndrome were older age, having a lower socioeconomic status and suffering from chronic health conditions, especially asthma. Our findings show that a significant proportion of seropositive children, particularly adolescents, experienced persistent COVID symptoms. While there is a need for further investigations, growing evidence of pediatric post-COVID urges early screening and primary care management.


  • Open Access

    Post-COVID syndrome prevalence and risk factors in children and adolescents: A population-based serological study

    by Roxane Dumont, Viviane Richard, Elsa Lorthe, Andrea Loizeau, Francesco Pennacchio, María-Eugenia Zaballa, Hélène Baysson, Mayssam Nehme, Anne Perrin, Arnaud G. L’huillier, et al.

    A bstract: Objectives: Post-COVID syndrome remain poorly studied in children and adolescents. In this study, we aimed to investigate the prevalence and risk factors of pediatric post-COVID in a population-based sample, stratifying by serological status. Study design: We used data from the SEROCoV-KIDS cohort study (State of Geneva, Switzerland), which included children (aged 6 months to 17 years) selected from random samples drawn from state registries or who had a household member participating in a COVID-19 seroprevalence study conducted by our group. Children were tested for anti-SARS-CoV-2 N antibodies. Parents filled in a questionnaire on persistent symptoms in their children (lasting over 12 weeks) compatible with post-COVID syndrome. Results: From December 1 st , 2021 to February 16 th , 2022, 1034 children were included, among whom 570 (55.1%) were seropositive. The sex- and age-adjusted prevalence of persistent symptoms among seropositive children was 9.1% (95%CI: 6.7;11.8) and 5.0% (95%CI: 3.0;7.1) among seronegatives, with an adjusted prevalence difference (ΔaPrev) of 4.1% (95%CI: 1.1;7.3). After stratification by age group, the prevalence was higher among adolescents aged 12-17 years (ΔaPrev=8.3%, 95%CI: 3.5;13.5) than among younger children (0.0%, 95%CI: −5.2;5.2 among 6-11 years old and 4.2%; 95%CI: −4.4;13.3 among 0-5 years old). The most frequently declared persistent symptoms among seropositives were smell loss, trouble concentrating and abdominal pain. Older age, having a chronic condition and lower socioeconomic conditions were identified as risk factors. Conclusion: A significant proportion of seropositive children, particularly adolescents, experienced persistent symptoms. While there is a need for further investigation, growing evidence of pediatric post-COVID syndrome urges early screening and primary care management.

  • Open Access

    Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school: A prospective longitudinal study

    by Elsa Lorthe, Mathilde Bellon, Grégoire Michielin, Julie Berthelot, María-Eugenia Zaballa, Francesco Pennacchio, Meriem Bekliz, Florian Laubscher, Fatemeh Arefi, Javier Perez-Saez, et al.

    To report a prospective epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak in a primary school. As part of a longitudinal, prospective, school-based surveillance study, this investigation involved repeated testing of 73 pupils, 9 teachers, 13 non-teaching staff and 26 household members of participants who tested positive, with rapid antigen tests and/or RT-PCR (Day 0–2 and Day 5–7), serologies on dried capillary blood samples (Day 0–2 and Day 30), contact tracing interviews and SARS-CoV-2 whole genome sequencing. We identified 20 children (aged 4 to 6 years from 4 school classes), 2 teachers and a total of 4 household members who were infected by the Alpha variant during this outbreak. Infection attack rates were between 11.8 and 62.0% among pupils from the 4 school classes, 22.2% among teachers and 0% among non-teaching staff. Secondary attack rate among household members was 15.4%. Symptoms were reported by 63% of infected children, 100% of teachers and 50% of household members. All analysed sequences but one showed 100% identity. Serological tests detected 8 seroconversions unidentified by SARS-CoV-2 virological tests. This study confirmed child-to-child and child-to-adult SARS-CoV-2 transmission and introduction into households. Effective measures to limit transmission in schools have the potential to reduce the overall community circulation.


  • Open Access

    Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva

    by Judith A. Bouman, Sarah Kadelka, Silvia Stringhini, Francesco Pennacchio, Benjamin Meyer, Sabine Yerly, Laurent Kaiser, Idris Guessous, Andrew S. Azman, Sebastian Bonhoeffer, et al.


  • Open Access

    Persistent symptoms among children and adolescents with and without anti-SARS-CoV-2 antibodies: a population-based serological study in Geneva, Switzerland

    by Roxane Dumont, Mayssam Nehme, Elsa Lorthe, Carlos de Mestral, Viviane Richard, Hélène Baysson, Francesco Pennacchio, Julien Lamour, Claire Semaani, María-Eugenia Zaballa, et al.

    A bstract: Background: It is now established that a significant proportion of adults experience persistent symptoms after SARS-CoV-2 infection. However, evidence for children and adolescents is still inconclusive. In this population-based study, we examine the proportion of children and adolescents reporting persistent symptoms after SARS-CoV-2 infection, as assessed by serological status, and compare this to a seronegative control group. Methods: We conducted a serosurvey in June-July 2021, recruiting 660 children and adolescents from 391 households selected randomly from the Geneva population. We tested participants for anti-SARS-CoV-2 antibodies targeting the nucleocapsid (N) protein to determine previous infection. A parent filled a questionnaire including questions on COVID-19-related symptoms lasting at least 2 weeks. Findings: Among children seropositive for anti-SARS-CoV-2 antibodies, the sex- and age-adjusted prevalence of symptoms lasting longer than two weeks was 18.3%, compared to 11.1% among seronegative children (prevalence difference (ΔaPrev)=7.2%, 95%CI:1.5-13.0). Main symptoms declared among seropositive children were fatigue (11.5%) and headache (11.1%). For 8.6% (aPrev, 95%CI: 4.7-12.5) of seropositives, these symptoms were declared to be highly limiting of daily activities. Adolescents aged 12-17 years had a higher adjusted prevalence of persistent symptoms (aPrev=29.1%, 95%CI:19.4-38.7) than younger children. Comparing seropositive and seronegative adolescents, the estimated prevalence of symptoms lasting over four weeks is 4.4% (ΔaPrev, 95%CI:-3.8-13.6). Interpretation: A significant proportion of children aged 12 to 17 years had symptoms lasting over two weeks after SARS-CoV-2 infection, with an estimated prevalence of symptoms lasting over 4 weeks of 4.4% in this age group. This represents a large number of adolescents in absolute terms, and should raise concern in the context of unknown long-term evolution of symptoms. Younger children appear to experience long-lasting symptoms less frequently, as no difference was observed between the seropositive and seronegative sample. Further studies with larger samples sizes are needed. Funding: Swiss Federal Office of Public Health, Geneva General Directorate of Health, HUG Private Foundation, SSPH+, Fondation des Grangettes.

  • Open Access

    Epidemiological, virological and serological investigation into a SARS-CoV-2 outbreak (Alpha variant) in a primary school: a prospective longitudinal study

    by Elsa Lorthe, Mathilde Bellon, Grégoire Michielin, Julie Berthelot, María-Eugenia Zaballa, Francesco Pennacchio, Meriem Bekliz, Florian Laubscher, Fatemeh Arefi, Javier Perez-Saez, et al.

    Background Twenty-one months into the pandemic, the extent to which young children get infected and transmit SARS-CoV-2 in school settings remains controversial, in particular with variants of concern. We report a prospective epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak in a primary school in Geneva, Switzerland, in April-May 2021. Methods This outbreak investigation is part of a longitudinal, prospective, primary school-based surveillance study (SEROCoV-Schools). It involved repeated testing of pupils and teachers and household members of participants who tested positive. Rapid antigen tests and/or real-time reverse transcription polymerase chain reaction were performed at Day 0-2 and Day 5-7; serologies on dried capillary blood samples were performed at Day 0-2 and Day 30. Contact tracing interviews and SARS-CoV-2 whole genome sequencing were carried out for positive cases. Results This SARS-CoV-2 outbreak caused by the Alpha variant involved 20 children aged 4 to 6 years from 4 classes, 2 teachers and 3 household members. Infection attack rates were between 11.8 and 62.0% among pupils from the 4 classes, 22.2% among teachers and 0% among non-teaching staff. Secondary attack rate among household members was 10.7%. Symptoms were reported by 63% of infected children, 100% of teachers and 66.7% of household members. All analysed sequences but one showed 100% identity. Serological tests detected 8 seroconversions unidentified by SARS-CoV-2 virological tests. Conclusions This study confirmed child-to-child and child-to-adult transmission of the infection. SARS-CoV-2 can spread rapidly between children and adults in school settings, and is thereby introduced into households. Effective measures to limit transmission in schools have the potential to reduce the overall community circulation. summary of the article’s main point As part of a prospective, primary school-based surveillance study, this SARS-CoV-2 outbreak investigation showed infection attack rates of 11.8% to 62.0% among pupils from 4 classes, 22.2% among teachers, 0% among non-teaching staff and 10.7% among household members, and confirmed child-to-child and child-to-adult transmission.


  • Open Access

    Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland

    by Silvia Stringhini, María-Eugenia Zaballa, Nick Pullen, Carlos de Mestral, Javier Perez-Saez, Roxane Dumont, Attilio Picazio, Francesco Pennacchio, Yaron Dibner, Sabine Yerly, et al.

    Limited data exist on SARS-CoV-2 infection rates across sectors and occupations, hindering our ability to make rational policy, including vaccination prioritization, to protect workers and limit SARS-CoV-2 spread. Here, we present results from our SEROCoV-WORK + study, a serosurvey of workers recruited after the first wave of the COVID-19 pandemic in Geneva, Switzerland. We tested workers (May 18—September 18, 2020) from 16 sectors and 32 occupations for anti-SARS-CoV-2 IgG antibodies. Of 10,513 participants, 1026 (9.8%) tested positive. The seropositivity rate ranged from 4.2% in the media sector to 14.3% in the nursing home sector. We found considerable within-sector variability: nursing home (0%–31.4%), homecare (3.9%–12.6%), healthcare (0%–23.5%), public administration (2.6%–24.6%), and public security (0%–16.7%). Seropositivity rates also varied across occupations, from 15.0% among kitchen staff and 14.4% among nurses, to 5.4% among domestic care workers and 2.8% among journalists. Our findings show that seropositivity rates varied widely across sectors, between facilities within sectors, and across occupations, reflecting a higher exposure in certain sectors and occupations.